Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.

Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
复制标题

DOI:
10.3892/mmr.2014.2891
复制
发表时间:
2015-03
影响因子:
3.4
通讯作者:
Zhu R
Zhu R
中科院分区:
医学4区
文献类型:
--
作者:
Liu B;Zhou W;Chen X;Xu F;Chen Y;Liu J;Zhang Q;Bao S;Chen N;Li M;Zhu R

文献摘要

参考文献

被引文献

相似文献

二氢杨梅素(DHM)是一种黄酮类化合物,具有很强的抗肿瘤活性。在本研究中,它表明,DHM显着抑制小鼠肝癌Hepal-6细胞的增殖和诱导凋亡。转化生长因子β(TGF-β)被认为是一种主要的促纤维化细胞因子,因此是治疗肝脏疾病的药物的常见靶标。本研究旨在研究TGF-β是否参与DHM触发的细胞活力抑制和凋亡诱导。采用MTT法检测DHM处理后Hepal-6细胞的存活率。TGF-β信号传导由Smads介导,并且烟酰胺腺嘌呤二核苷酸磷酸氧化酶4(N 0X 4)是活性氧类ROS产生的关键调节剂。通过蛋白质印迹分析来评估TGF-β、Smad 3、磷酸化(p)-Smad 2/3和NOX 4蛋白表达水平。采用定量聚合酶链反应检测TGF-β和NOX 4基因表达水平。结果表明,DHM呈浓度依赖性下调TGF-β、Smad 3、p-Smad 2/3和NOX 4的表达。细胞计数分析表明,DHM也以浓度依赖性方式抑制Hepal-6细胞生长。DHM处理后TGF-β表达显著降低。总之,本研究的结果定义并支持DHM的新功能,表明其通过下调小鼠肝细胞癌Hepal-6细胞中TGF-β/Smad 3信号通路的ROS产生来诱导细胞凋亡。
Dihydromyricetin (DHM) is a flavonoid compound which possesses potent antitumor activity. In the present study, it was demonstrated that DHM significantly inhibited proliferation and induced apoptosis in mouse hepatocellular carcinoma Hepal-6 cells. Transforming growth factor β (TGF-β) is recognized as a major profibrogenic cytokine and is therefore a common target for drugs in the treatment of liver disease. The present study aimed to investigate whether TGF-β was involved in DHM-triggered cell-viability inhibition and apoptosis induction. An MTT assay was used to evaluate the viability of Hepal-6 cells following DHM treatment. TGF-β signalling is mediated by Smads and nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) is a crucial regulator of reactive oxygen species ROS production. TGF-β, Smad3, phosphorylated (p)-Smad2/3 and NOX4 protein expression levels were evaluated by western blot analysis. TGF-β and NOX4 gene expression levels were determined by quantitative polymerase chain reaction. The results indicated that DHM downregulated TGF-β, Smad3, p-Smad2/3 and NOX4 in a concentration-dependent manner. A cell counting assay indicated that DHM also inhibited Hepal-6 cell growth in a concentration-dependent manner. TGF-β expression was significantly decreased following DHM treatment. In conclusion, the results of the present study defined and supported a novel function for DHM, indicating that it induced cell apoptosis by downregulating ROS production via the TGF-β/Smad3 signaling pathway in mouse hepatocellular carcinoma Hepal-6 cells.
DOI: 10.1128/jvi.01059-09
发表时间: 2009-12-15
影响因子: 5.4
作者:
Boudreau, Howard E.;Emerson, Suzanne U.;Leto, Thomas L.
通讯作者: Leto, Thomas L.
DOI: 10.1158/1541-7786.mcr-08-0558
发表时间: 2009-08-01
影响因子: 5.2
作者:
Dzwonek, Joanna;Preobrazhenska, Olena;Verschueren, Kristin
通讯作者: Verschueren, Kristin
DOI: 10.1101/cshperspect.a003277
发表时间: 2011-01-01
影响因子: 7.2
作者:
Moses, Harold;Barcellos-Hoff, Mary Helen
通讯作者: Barcellos-Hoff, Mary Helen
DOI: 10.1016/j.freeradbiomed.2009.07.023
发表时间: 2009-11-01
影响因子: 7.4
作者:
Brown, David I.;Griendling, Kathy K.
通讯作者: Griendling, Kathy K.
DOI: 10.1002/hep.24128
发表时间: 2011-05
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Baek, Hye Jung;Pishvaian, Michael J.;Tang, Yi;Kim, Tae Hyun;Yang, Shaoxian;El Zouhairi, Majed;Mendelson, Jon;Shetty, Kirti;Kallakury, Bhaskar;Berry, Deborah L.;Shin, Kyung Hwan;Mishra, Bibhuti;Reddy, E. Premkumar;Kim, Sang Soo;Mishra, Lopa
通讯作者: Mishra, Lopa